4.4 Article

Electronic Nicotine Delivery Systems (ENDS) use Among Members of a Community Engagement Program

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

A scoping review of studies on the health impact of electronic nicotine delivery systems

Cother Hajat et al.

Summary: The scoping review on health outcomes from electronic nicotine delivery systems (ENDS) found that there is no causative evidence for harmful cardiovascular disease (CVD) outcomes with ENDS use, and it may be beneficial for hypertensive patients. Switching from cigarettes to e-cigarettes can reduce exacerbations of chronic obstructive pulmonary disease (COPD) without long-term respiratory harm. However, further research is needed on mental health, cancer, and mortality outcomes to draw definitive conclusions.

INTERNAL AND EMERGENCY MEDICINE (2022)

Article Oncology

The HealthStreet Cancer Survivor Cohort: a Community Registry for Cancer Research

Ting-Yuan David Cheng et al.

Summary: This report describes a cancer survivor cohort from a community engagement program and compares characteristics and willingness to participate in health research between the cancer survivors and non-cancer community members. The study found that cancer survivors from this program are diverse in terms of geography, race, and social determinants of health, and have a higher interest in participating in research.

JOURNAL OF CANCER SURVIVORSHIP (2022)

Article Public, Environmental & Occupational Health

Smoking and E-Cigarette Use Among US Adults During the COVID-19 Pandemic

Sara M. Kalkhoran et al.

Summary: This study aims to understand changes in combustible cigarette and E-cigarette use among U.S. adults during the COVID-19 pandemic. The results show that most cigarette smokers and E-cigarette users perceive an increased health risk related to COVID-19 and have attempted to quit. Some cigarette smokers increased their product use due to higher stress. The study recommends proactive provision of cessation support to mitigate the stress-related increases in product use during the pandemic.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2022)

Review Primary Health Care

Global youth vaping and respiratory health: epidemiology, interventions, and policies

Lynnette Nathalie Lyzwinski et al.

Summary: The usage of e-cigarettes, also known as vaping products, is being widely recognized as a global public health issue. One significant challenge is the marketing of these products to minors, leading to an increase in usage among teenagers and children. E-cigarettes expose minors to unnecessary health risks, including respiratory problems and cognitive impairment. They are also linked to the initiation of other substances, such as cigarettes and cannabis, which compounds the health risks for dual users. More interventions and stricter public health policies are needed to prevent and reduce e-cigarette usage among minors.

NPJ PRIMARY CARE RESPIRATORY MEDICINE (2022)

Article Medicine, General & Internal

Assessment of Patterns in e-Cigarette Use Among Adults in the US, 2017-2020

Ellen Boakye et al.

Summary: This study examined recent patterns of e-cigarette use among adults in the US. The prevalence of current e-cigarette use slightly decreased from 2018 to 2020, especially among young adults aged 18 to 20 years. However, the prevalence of daily e-cigarette use consistently increased, particularly among young adults aged 21 to 24 years.

JAMA NETWORK OPEN (2022)

Review Substance Abuse

Risk and safety profile of electronic nicotine delivery systems (ENDS): an umbrella review to inform ENDS health communication strategies

Taghrid Asfar et al.

Summary: This umbrella review aims to summarize the evidence about the risk and safety health profile of electronic nicotine delivery systems (ENDS) in order to inform ENDS health communication strategies. The review found high-level evidence that ENDS exposes users to toxic substances, increases the risk of respiratory disease, leads to nicotine dependence, causes serious injuries due to explosion or poisoning, increases smoking cessation in clinical trials but not in observational studies, increases combustible cigarette (CC) initiation, and exposure to ENDS marketing increases its use/intention to use. The evidence was moderate for ENDS association with mental health and substance use, limited-suggestive for cardiovascular effects, and limited-not-conclusive for cancer, ear, ocular, and oral diseases, as well as pregnancy outcomes. The communication about ENDS should focus on the high-level evidence regarding toxicity, nicotine addiction, respiratory disease, ENDS-specific harm (explosion, poisoning), and anti-ENDS industry sentiment.

TOBACCO CONTROL (2022)

Article Public, Environmental & Occupational Health

Notes from the Field: E-cigarette Use Among Middle and High School Students — United States, 2022

Maria Cooper et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Review Public, Environmental & Occupational Health

E-Cigarettes-a review of the evidence-harm versus harm reduction

Susan Feeney et al.

Summary: The World Health Organization estimates that there are 1.1 billion smokers worldwide and 7 million tobacco-related deaths annually. Electronic nicotine delivery systems (ENDS), including e-cigarettes, are increasingly being used as a smoking cessation option. However, there are known risks and harms associated with using e-cigarettes, such as varying levels of toxicants, nicotine, and carcinogens, which can put users at risk for lung diseases and COVID-19 similar to smokers.

TOBACCO USE INSIGHTS (2022)

Article Medicine, General & Internal

Vaping-Associated Lung Injury: A Review

Marissa O'Callaghan et al.

Summary: This review article provides an overview of the background, popularity, and mechanism of lung injury caused by e-cigarette or vaping use.

MEDICINA-LITHUANIA (2022)

Article Public, Environmental & Occupational Health

Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms

Joy L. Hart et al.

Summary: Studies have shown that using electronic nicotine delivery systems (ENDS) can lead to clinical symptoms, including E-CIGS related lung injury-like symptoms. Research found that participants who used refillable devices, varied nicotine content, flavored products, or made their own e-liquids were more likely to experience clinical symptoms.

PREVENTIVE MEDICINE REPORTS (2021)

Review Medicine, General & Internal

Electronic cigarettes for smoking cessation

Jamie Hartmann-Boyce et al.

Summary: Electronic cigarettes (ECs) show moderate effectiveness in helping smokers achieve long-term smoking abstinence, especially those containing nicotine compared to nicotine replacement therapy. However, more studies are needed to confirm the effect size and ensure safety.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Article Environmental Sciences

Users' Modifications to Electronic Nicotine Delivery Systems (ENDS): Interviews with ENDS Enthusiasts

Yachao Li et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Health Care Sciences & Services

Modifications to Electronic Nicotine Delivery Systems: Content Analysis of YouTube Videos

Zachary B. Massey et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2020)

Article Public, Environmental & Occupational Health

The association between statewide vaping prevalence and COVID-19

Dongmei Li et al.

PREVENTIVE MEDICINE REPORTS (2020)

Article Public, Environmental & Occupational Health

JUUL and Combusted Cigarettes Comparably Impair Endothelial Function

Poonam Rao et al.

TOBACCO REGULATORY SCIENCE (2020)

Article Public, Environmental & Occupational Health

Sales of Nicotine-Containing Electronic Cigarette Products: United States, 2015

Kristy L. Marynak et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2017)

Review Respiratory System

Epidemiology of COPD

C. Raherison et al.

EUROPEAN RESPIRATORY REVIEW (2009)